Drugs / S-1360
S-1360
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00046332 | Jun 2002 → Jan 2003 | HIV infectious disease | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S-1360 | “A Phase II, Randomized, Placebo-controlled Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of Four Oral Doses of S-1360 Versus Placebo Over 10 Days...” NCT00046332 ↗ |
| Known as | GSK-S-1360 | ChEMBL registry synonym — accepted as the source's own label CHEMBL218227 ↗ |
| Known as | GW-810781 | ChEMBL registry synonym — accepted as the source's own label CHEMBL218227 ↗ |
| Modality | Small molecule | — CHEMBL218227 ↗ |